Matthew K Wedemeyer, MD
Pain Management · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 4
Offices
4 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wedemeyer’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A87925 · Current
Licensed to practise in California · since 2004 · expires 2027-07-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$11,069
Medicare paid this office $11,069 for 74 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 38 | $4,449 | $95 |
| New patient visit (60+ min) | 16 | $2,511 | $157 |
Who their Medicare patients are
74 Original Medicare patients in 2024. Average age 72 · Women 64% · Also on Medicaid 31% · Health risk score 1.58. Above the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 72% · Diabetes 34% · Depression 32% · Coronary heart disease 28% · Cancer 24% · Chronic kidney disease 19% · Atrial fibrillation 15%.
The office billed $158,674, Medicare allowed $14,424 and paid $11,069; for 107 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 74 | 107 | 72 | 1.58 | $158,674 | $11,069 |
| 2023 | 81 | 143 | 73 | 1.46 | $196,878 | $12,801 |
| 2022 | 90 | 152 | 71 | 1.47 | $187,636 | $14,099 |
| 2021 | 108 | 205 | 70 | 1.45 | $301,325 | $18,487 |
| 2020 | 102 | 168 | 69 | 1.48 | $197,499 | $13,139 |
| 2019 | 109 | 208 | 68 | 1.35 | $228,034 | $14,968 |
| 2018 | 98 | 192 | 67 | 1.41 | $185,650 | $14,988 |
| 2017 | 114 | 197 | 68 | 1.42 | $146,903 | $16,433 |
| 2016 | 130 | 241 | 68 | 1.52 | $234,153 | $19,642 |
| 2015 | 128 | 244 | 68 | 1.34 | $242,952 | $19,184 |
| 2014 | 132 | 255 | 65 | 1.25 | $195,719 | $18,471 |
| 2013 | 153 | 216 | 66 | 1.55 | $174,970 | $18,220 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 40 | $4,207 | $82 |
| New patient visit (60+ min) | 17 | $2,516 | $148 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 12 | $85 | $5 |
2022: 3 services
| New patient visit (60+ min) | 28 | $4,280 | $153 |
| Return visit (30+ min) | 36 | $4,255 | $82 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $67 | $5 |
2021: 7 services
| New patient visit (60+ min) | 20 | $3,362 | $168 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $3,334 | $222 |
| Return visit (30+ min) | 26 | $2,480 | $86 |
| Long return visit (40+ min) | 13 | $1,710 | $132 |
| Injection of substance into lower spine canal using imaging guidance | 13 | $1,122 | $86 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 11 | $943 | $59 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $325 | $11 |
2020: 4 services
| New patient visit (60+ min) | 28 | $3,371 | $120 |
| Return visit (30+ min) | 20 | $1,374 | $60 |
| Long return visit (40+ min) | 15 | $1,335 | $89 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $167 | $9 |
2019: 7 services
| New patient visit (60+ min) | 20 | $2,956 | $148 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,424 | $102 |
| Injection of substance into lower spine canal using imaging guidance | 11 | $999 | $83 |
| Long return visit (40+ min) | 12 | $999 | $83 |
| Return visit (30+ min) | 14 | $994 | $52 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $730 | $56 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 33 | $374 | $10 |
2018: 6 services
| New patient visit (60+ min) | 21 | $3,129 | $149 |
| Return visit (30+ min) | 19 | $1,625 | $68 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,401 | $93 |
| Long return visit (40+ min) | 11 | $1,086 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $650 | $54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $274 | $11 |
2017: 5 services
| New patient visit (60+ min) | 34 | $4,507 | $133 |
| Long return visit (40+ min) | 26 | $2,478 | $95 |
| Return visit (30+ min) | 27 | $2,316 | $66 |
| Injection of substance into lower spine canal using imaging guidance | 11 | $907 | $82 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $217 | $11 |
2016: 5 services
| New patient visit (60+ min) | 30 | $4,105 | $137 |
| Return visit (30+ min) | 26 | $2,313 | $68 |
| Long return visit (40+ min) | 20 | $1,983 | $99 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $1,961 | $109 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 31 | $1,434 | $38 |
2015: 4 services
| New patient visit (60+ min) | 22 | $3,070 | $140 |
| Return visit (30+ min) | 26 | $1,839 | $68 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 29 | $1,307 | $38 |
| Injections of substances into lower or sacral spine | 14 | $1,080 | $77 |
2014: 7 services
| New patient visit (60+ min) | 22 | $3,099 | $141 |
| Return visit (30+ min) | 32 | $2,676 | $59 |
| Long return visit (40+ min) | 19 | $1,778 | $94 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 37 | $1,525 | $38 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 13 | $1,422 | $109 |
| Injections of substances into lower or sacral spine | 14 | $924 | $66 |
| Fluoroscopic guidance for spine or back muscle injection | 20 | $547 | $27 |
2013: 6 services
| New patient visit (60+ min) | 32 | $4,538 | $142 |
| Return visit (30+ min) | 32 | $2,689 | $64 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 25 | $2,359 | $94 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $1,554 | $91 |
| Long return visit (40+ min) | 14 | $1,423 | $95 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $746 | $53 |
Drugs they prescribed that Part D paid
$1,996
Pharmacies billed $1,996 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
40 generic and fewer than 11 brand-name prescriptions · $1,996 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 17 | $167 | $10 |
Year by year
| 2024 | 43 | 21 | None | None | $1,996 |
| 2023 | 60 | 19 | None | 20% | $6,095 |
| 2022 | 65 | 22 | 22% (14) | None | $1,944 |
| 2021 | 31 | 19 | None | None | $1,193 |
| 2020 | 55 | 23 | 22% (12) | None | $2,828 |
| 2019 | 54 | 24 | None | None | $7,347 |
| 2018 | 71 | 32 | None | 31% | $10,779 |
| 2017 | 143 | 63 | 26% (37) | 18% | $18,793 |
| 2016 | 99 | 35 | 12% (12) | 13% | $8,716 |
| 2015 | 103 | 43 | 35% (36) | 17% | $6,833 |
| 2014 | 129 | 54 | 43% (56) | 24% | $15,461 |
| 2013 | 80 | 35 | 20% (16) | 26% | $7,657 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Gabapentin | 16 | $376 | $23 |
2022: 1 drug
| Gabapentin | 24 | $674 | $28 |
2020: 2 drugs
| Pregabalin | 14 | $599 | $43 |
| Gabapentin | 11 | $457 | $42 |
2019: 2 drugs
| Diclofenac | 11 | $2,107 | $192 |
| Gabapentin | 14 | $170 | $12 |
2018: 3 drugs
| Lyrica | 11 | $9,061 | $824 |
| Gabapentin | 16 | $298 | $19 |
| Diclofenac | 11 | $149 | $14 |
2017: 4 drugs
| Lyrica | 12 | $8,266 | $689 |
| Duloxetine | 11 | $538 | $49 |
| Hydrocodone-Acetaminophen | 11 | $465 | $42 |
| Gabapentin | 28 | $432 | $15 |
2016: 2 drugs
| Gabapentin | 18 | $473 | $26 |
| Duloxetine | 11 | $308 | $28 |
2015: 3 drugs
| Gabapentin | 19 | $526 | $28 |
| Methadone | 11 | $295 | $27 |
| Baclofen | 11 | $94 | $9 |
2014: 2 drugs
| Gabapentin | 28 | $695 | $25 |
| Hydrocodone-Acetaminophen | 26 | $517 | $20 |
2013: 1 drug
| Gabapentin | 21 | $832 | $40 |
Money from drug and device companies
$21 in 2019
A payment is not proof that care is biased.
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $21 | 1 payment
|
See the published payment
| Scilex Pharmaceuticals | Meals · 2019-01-30 | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $21 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1699983577
- Licence
- CA A87925California A87925: Current · expires 2027-07-31
- Trained
- University of Southern California Keck School of Medicine, 2002
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X); Federal specialty code 207L00000X (207L00000X); Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 208100000X (208100000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-05-21
- NPI last updated
- 2024-04-11
- NPI record certified
- 2024-04-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 450 Broadway St, Redwood City, CA, 94063